Show Notes
Transitions are hard. The transition from pediatric to adult care in type 1 diabetes (T1D) can be especially fraught. Add in barriers beyond just living with diabetes and that adds a whole other layer of complexity, but researchers around the world are working to ensure better outcomes for all.
Today on the Diabetes Canada Podcast we’re talking to Dr. Rayzel Shulman about the transition from pediatric to adult care in T1D. Dr. Shulman is a pediatric endocrinologist at Sick Kids Hospital and an Assistant Professor at the University of Toronto. Her research is focused on developing and evaluating health services interventions to improve outcomes and the quality of care for youth with T1D as they transition to adulthood.
More from Diabetes Canada Podcast
Diabetic ketoacidosis, or DKA, is one of the most feared complications of type 1 diabetes. That’s why researchers are looking for new and innovative ways to increase awareness of what DKA is and how it can be prevented.
How can we change the conversation about diabetes? For Diabetes Awareness Month, that’s a question Diabetes Canada is tackling head on.
How can we change the conversation about diabetes? For Diabetes Awareness Month, that’s a question Diabetes Canada is tackling head on.
Many people are at risk for both diabetes and heart attacks. Millions of people take statin drugs to lower bad cholesterol and reduce the risk of heart attacks. But could these drugs also increase the risk for type 2 diabetes?
As technology in type 1 diabetes becomes more advanced, we are starting to see an increase in personalized therapies. Whether someone is using hybrid closed loop or multiple daily injections, there are options being studied to make living with diabetes easier to manage.